Bayesian latent variable collapsing model for detecting rare variant interaction effect in twin study

Genetic Epidemiology

Volumn 38, Issue 4, 2014, Pages 310-324

  He, Liang ^a   Sillanpää, Mikko J ^b   Ripatti, Samuli ^a,c   Pitkäniemi, Janne ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d FINNISH CANCER REGISTRY   (Finland)

Author keywords

Bayesian collapsing model; Genetic association; LDL C; Rare variant; Twin study

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALLELE; ARTICLE; BAYES THEOREM; BAYESIAN LATENT VARIABLE COLLAPSING MODEL; GENE INTERACTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; PHENOTYPE; SIMULATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL MODEL; TWINS;

BAYESIAN COLLAPSING MODEL; GENETIC ASSOCIATION; LDL-C; RARE VARIANT; TWIN STUDY;

ALLELES; BAYES THEOREM; CHOLESTEROL, LDL; FINLAND; GENETIC VARIATION; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; TWINS;

EID: 84899097486     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21804     Document Type: Article

References (51)

1. Al-Bustan SA, Al-Serri AE, Annice BG, Alnaqeeb MA, Ebrahim GA. 2013. Re-sequencing of the APOAI promoter region and the genetic association of the -75G > A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population. BMC Med Genet 14:90.
2. Bafumi J, Gelman A, Park DK, Kaplan N. 2005. Practical issues in implementing and understanding Bayesian ideal point estimation. Polit Anal 13:171-187.
3. Basu S, Pan W. 2011. Comparison of statistical tests for disease association with rare variants. Genet Epidemiol 35:606-619.
4. Becker KG. 2004. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62:309-317.
5. Boker S, Neale M, Maes H, Wilde M, Spiegel M, Brick T, Spies J, Estabrook R, Kenny S, Bates T and others 2011. OpenMx: an open source extended structural equation modeling framework. Psychometrika 76:306-317.
6. Bossé Y, Chagnon YC, Després J-P, Rice T, Rao DC, Bouchard C, Pérusse L, Vohl M-C. 2004. Genome-wide linkage scan reveals multiple susceptibility loci influencing lipid and lipoprotein levels in the Quebec Family Study. J Lipid Res 45:419-426.
7. Che X, Xu S. 2010. Significance test and genome selection in Bayesian shrinkage analysis. Int J Plant Genomics 2010:893206. doi:10.1155/2010/893206.
8. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. 2010. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11:446-450.
9. Frazer KA, Murray SS, Schork NJ, Topol EJ. 2009. Human genetic variation and its contribution to complex traits. Nat Rev Genet 10:241-251.
10. Frigyik BA, Kapila A, Gupta MR. 2010. Introduction to the Dirichlet Distribution and Related Processes. Seattle, WA: University of Washington.
11. Gelman A, Hill J. 2006. Data Analysis Using Regression and Multilevel/Hierarchical Models, 1st ed. Cambridge, UK: Cambridge University Press.
12. Gerke J, Lorenz K, Cohen B. 2009. Genetic interactions between transcription factors cause natural variation in yeast. Science 323:498-501.
13. Gibson G. 2012. Rare and common variants: twenty arguments. Nat Rev Genet 13:135-145.
14. Good IJ. 1992. The Bayes/non-Bayes compromise: a brief review. J Am Stat Assoc 87(419):597-606.
15. Han F, Pan W. 2010. A data-adaptive sum test for disease association with multiple common or rare variants. Hum Hered 70:42-54.
16. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK, Manolio TA. 2011. A catalog of published genome-wide association studies. Available at: www.genome.gov/gwastudies.
17. Hoffmann TJ, Marini NJ, Witte JS. 2010. Comprehensive approach to analyzing rare genetic variants. PloS One 5:e13584.
18. Howie BN, Donnelly P, Marchini J. 2009. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5:e1000529.
19. Ioannidis JPA. 2008. Effect of formal statistical significance on the credibility of observational associations. Am J Epidemiol 168:374-383.
20. Iyengar SK, Elston RC. 2007. The genetic basis of complex traits: rare variants or "common gene, common disease"? Methods Mol Biol Clifton NJ 376:71-84.
21. Jeffreys H. 1998. Theory of Probability, 3rd ed. New York, NY: Oxford University Press.
22. Kass RE, Raftery AE. 1995. Bayes factors. J Am Stat Assoc 90(430):773-795.
23. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS and others 2008. Six new loci associated with blood low-density lipoprotein cholesterol high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40:189-197.
24. Ladouceur M, Dastani Z, Aulchenko YS, Greenwood CMT, Richards JB. 2012. The empirical power of rare variant association methods: results from sanger sequencing in 1, 998 individuals. PLoS Genet 8:e1002496.
25. Lange LA, Hu Y, Zhang H, Xue C, Schmidt EM, Tang Z-Z, Bizon C, Lange EM, Smith JD, Turner EH and others 2014. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am J Hum Genet 94:233-245.
26. Li B, Leal SM. 2008. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 83: 311-321.
27. Li Q, Yin R-X, Yan T-T, Miao L, Cao X-L, Hu X-J, Aung LHH, Wu D-F, Wu J-Z, Lin W-X. 2011. Association of the GALNT2 gene polymorphisms and several environmental factors with serum lipid levels in the Mulao and Han populations. Lipids Health Dis 10:160.
28. Liu DJ, Leal SM. 2010. A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions. PLoS Genet 6:e1001156.
29. Madsen BE, Browning SR. 2009. A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 5:e1000384.
30. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A and others 2009. Finding the missing heritability of complex diseases. Nature 461:747-753.
31. Mathieson I, McVean G. 2012. Differential confounding of rare and common variants in spatially structured populations. Nat Genet 44:243-246.
32. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JPA, Hirschhorn JN. 2008. Genome-wide association studies for complex traits: consensus uncertainty and challenges. Nat Rev Genet 9:356-369.
33. Meyers KJ, Chu J, Mosley TH, Kardia SL. 2010. SNP-SNP interactions dominate the genetic architecture of candidate genes associated with left ventricular mass in african-americans of the GENOA study. BMC Med Genet 11:160.
34. Morey RD, Rouder JN. 2011. Bayes factor approaches for testing interval null hypotheses. Psychol Methods 16:406-419.
35. Morris AP, Zeggini E. 2010. An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol 34:188-193.
36. Neale BM, Rivas MA, Voight BF, Altshuler D, Devlin B, Orho-Melander M, Kathiresan S, Purcell SM, Roeder K, Daly MJ. 2011. Testing for an unusual distribution of rare variants. PLoS Genet 7:e1001322.
37. Nelder JA, Wedderburn RWM. 1972. Generalized linear models. J R Stat Soc Ser Gen 135:370-384.
38. Oualkacha K, Dastani Z, Li R, Cingolani PE, Spector TD, Hammond CJ, Richards JB, Ciampi A, Greenwood CMT. 2013. Adjusted sequence kernel association test for rare variants controlling for cryptic and family relatedness. Genet Epidemiol 37:366-376.
39. Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA and others 2008. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322:1702-1705.
40. Price AL, Kryukov GV, de Bakker PIW, Purcell SM, Staples J, Wei L-J, Sunyaev SR. 2010. Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 86:832-838.
41. Quintana MA, Berstein JL, Thomas DC, Conti DV. 2011. Incorporating model uncertainty in detecting rare variants: the Bayesian risk index. Genet Epidemiol 35:638-649.
42. Robert CP. 1995. Simulation of truncated normal variables. Stat Comput 5:121-125.
43. Robinson R. 2010. Common disease multiple rare (and distant) variants. PLoS Biol 8:e1000293.
44. Stephens M, Balding DJ. 2009. Bayesian statistical methods for genetic association studies. Nat Rev Genet 10:681-690.
45. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun G, and others. 2012. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337:64-69.
46. Trip MD, Smulders YM, Wegman JJ, Hu X, Boer JMA, ten Brink JB, Zwinderman AH, Kastelein JJP, Feskens EJM, Bergen AAB. 2002. Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease. Circulation 106:773-775.
47. van Dongen J, Slagboom PE, Draisma HHM, Martin NG, Boomsma DI. 2012. The continuing value of twin studies in the omics era. Nat Rev Genet 13:640-653.
48. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM and others 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169.
49. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. 2011. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89:82-93.
50. Yi N, Liu N, Zhi D, Li J. 2011. Hierarchical generalized linear models for multiple groups of rare and common variants: jointly estimating group and individual-variant effects. PLoS Genet 7:e1002382.
51. Yi N, Zhi D. 2011. Bayesian analysis of rare variants in genetic association studies. Genet Epidemiol 35:57-69.